Good MorningEquity markets rebounded on Wednesday but it is far too soon to call the bottom. The move comes in tandem with a top in oil prices but it is far too soon to call it the end of higher prices as well. The key takeaway for traders is that WTI is still trading well above the $100 level and will be a driving force for inflation while the S&P 500 are trading below a key resistance point. The S&P 500 broke through the 4,300 level on Monday and there is still evidence of downward pressure in the charts.
The next test for the market could come as soon as Thursday in the form of the CPI. The CPI is expected to accelerate at the headline and core levels and to levels not seen in decades. The news will put added pressure on the FOMC in the face of rising wages and higher oil prices that are sure to drive inflation as soon as the present quarter. Featured: Trump’s treachery (Ad) 
|
Markets | | | Many of the biggest technology companies could just be getting started in terms of their growth potential and innovation, which means that holding onto shares over the years could be a very wise decision.
Read the Full Story |
|
|
Markets | | | In the world of stock investing sometimes boring is good. Here we focus on three attractive low risk stocks for the current geopolitical crisis. Conservative, or low-risk, stocks are defined any number of ways from the simple beta metric (sensitivity to broader market movements) to the sector in which they reside. Read the Full Story |
|
Markets | | |
On the heels of OxyContin maker Purdue Pharma asking a federal judge to approve a $6 billion nationwide settlement due to the overdose and addiction crisis, a new company will form following the U.S. Bankruptcy Court chapter 11 plan of reorganization. The resulting company is known as Knoa Pharma ... Read the Full Story |
|
From Our PartnersJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." | | | Click here to watch the demo… |
|
Politics | | | Western sanctions are dealing a severe blow to Russia's economy. The ruble is plunging, foreign businesses are fleeing and sharply higher prices are in the offing. Familiar products may disappear from stores, and middle-class achievements like foreign vacations are in doubt.
Beyond t... Read the Full Story |
|
Markets | | | Steakhouse operator Ruths Hospitality Group (NASDAQ: RUTH) stock have illustrated relative strength amid the sell-off in benchmark indexes. The Company experienced over 60% top-line growth in Q4 2021 as it returns to sales growth despite the onset of the Omicron variant. Inflationary pressures were ... Read the Full Story |
|
|
Politics | | | The latest developments on the Russia-Ukraine war:
LONDON — German fashion brand Hugo Boss and U.S. hotel chain Hilton are the latest brands to pause their Russian businesses over the Ukraine invasion.
Hugo Boss said Thursday that it has temporarily closed its stores an... Read the Full Story |
|
Politics | | | The latest developments on the Russia-Ukraine war:
ISTANBUL — Talks between the foreign ministers of Russia and Ukraine are underway on the sidelines of a diplomatic summit in Turkey.
An official photograph showed Russia’s Sergey Lavrov flanked by two advisers sitting a... Read the Full Story |
|
Politics | | | The latest developments on the Russia-Ukraine war:
LONDON — Britain has imposed a travel ban and asset freezes on seven more wealthy Russians, including Roman Abramovich, the billionaire owner of Premier League soccer club Chelsea.
The government said Thursday that Abra... Read the Full Story |
|
Politics | | | Britain’s armed forces minister says Russia’s strike on a hospital in Mariupol is a war crime, and warned President Vladimir Putin that using chemical weapons in Ukraine could draw “an international response.” Read the Full Story |
|
Stocks | | | Campbells Soup Company (NYSE: CPB) is among the more attractive consumer discretionary stocks and its shares just went on sale. The stock is trading at only 15X its earnings while yielding over 3.5% with earnings improvement and dividend growth in the forecast. Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patients with viral infections. Its lead product candidate is AT-527, an oral antiviral candidate that is in Phase 3 SUNRISE-3 clinical trial for the treatment of patients with COVID-19. The company also develops bemnifosbuvir in combination with ruzasvir, which is in Phase 2 clinical trial, for the treatment of hepatitis C virus (HCV); and a protease inhibitor for the treatment of COVID-19. It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of Ruzasvir, an NS5A inhibitor, for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts. | | View Today's Stock Pick |
|
